Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
InnoCan Pharma (DE:IP4)
FRANKFURT:IP4
InnoCan Pharma (IP4) Stock Price & Analysis
2 Followers
IP4 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.13 - €0.35
Previous Close€0.18
Volume0.00
Average Volume (3M)56.03K
Market Cap
€51.41M
Enterprise Value€48.08M
Total Cash (Recent Filing)$3.88M
Total Debt (Recent Filing)$33.00K
Price to Earnings (P/E)―
Beta0.83
Next Earnings
Aug 26, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding280,661,437
10 Day Avg. Volume39,460
30 Day Avg. Volume56,030
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)13.64
Price to Sales (P/S)3.73
Price to Cash Flow (P/CF)-10.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.52
Enterprise Value/Gross Profit4.01
Enterprise Value/Ebitda-14.21
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
InnoCan Pharma News
PremiumCompany Announcements
InnoCan Pharma’s Drug Shows Promise in Animal Trials
PremiumCompany Announcements
InnoCan Pharma Soars with Q1 Revenue Boost
PremiumCompany Announcements
InnoCan Pharma Advances Non-Opioid Pain Treatment
PremiumCompany Announcements
Innocan Pharma’s CBD Therapy Aids Injured Donkey
PremiumCompany Announcements
Innocan Pharma Seeks FDA Nod for Pain Therapy
PremiumCompany Announcements
Innocan Pharma’s Revenues Soar in 2023
PremiumCompany Announcements
Innocan Pharma Advances Towards FDA ApprovalIP4 FAQ
What was InnoCan Pharma’s price range in the past 12 months?
InnoCan Pharma lowest stock price was €0.13 and its highest was €0.35 in the past 12 months.
What is InnoCan Pharma’s market cap?
Currently, no data Available
When is InnoCan Pharma’s upcoming earnings report date?
InnoCan Pharma’s upcoming earnings report date is Aug 26, 2024 which is in 71 days.
How were InnoCan Pharma’s earnings last quarter?
Currently, no data Available
Is InnoCan Pharma overvalued?
According to Wall Street analysts InnoCan Pharma’s price is currently Overvalued.
Does InnoCan Pharma pay dividends?
InnoCan Pharma does not currently pay dividends.
What is InnoCan Pharma’s EPS estimate?
InnoCan Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does InnoCan Pharma have?
Currently, no data Available
What happened to InnoCan Pharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of InnoCan Pharma?
Currently, no hedge funds are holding shares in DE:IP4
---
InnoCan Pharma Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
2.64%
12-Months-Change
Fundamentals
Return on Equity
-108.53%
Trailing 12-Months
Asset Growth
41.29%
Trailing 12-Months
Company Description
InnoCan Pharma
InnoCan Pharma Corp is a Canada based company engaged in the research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products. Its brands include Shir and Relief & Go.
---
Technical Analysis
Heron Therapeutics
―
Corbus Pharmaceuticals
―
Aurora Cannabis
―
Tilray
―
InnoCan Pharma
―
---